Trial Profile

A clinical study of ART12.11 for Anxiety

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 23 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cannabidiol (Primary)
Indications Anxiety
Focus Adverse reactions

Most Recent Events

12 Nov 2024 According to an Artelo Biosciences media release, the Company is expecting to initiate this trial in 2025.
03 Jun 2024 New trial record
29 May 2024 According to an Artelo Biosciences media release, the Company is currently developing an optimized tablet of ART12.11 for planned clinical studies.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com